SavedAdd your journal

Journals / Meandros Medical And Dental Journal / 2011 / Cilt: 12 Sayı: 2

Diagnosis of Systemic Lupus Erythematosus in a Patient with Generalized Lymphadenopathy: A Case Report

YAYGIN LENFADENOPATİ NEDENİ İLE BAŞVURAN HASTADA SİSTEMİK LUPUS ERİTEMATOZİS TANISI: OLGU SUNUMU

İbrahim Halil TÜRKBEYLER
Yavuz PEHLİVAN
Gazi ÇÖMEZ
Orhan ZENGİN
Fatih GÖKTEPE
Ahmet Mesut ONAT
Pages
45–47
Publication Date
2011-08-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

SLE diagnosis should be considered in patients researched for lymphadenopathy etiology.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Lymphadenopathy (LAP) is defined as abnormality in the size and character of lymph node.
📊
Key Findings & Data:Lymphadenopathy emerges due to increase of inflammatory cells in lymph node or invasion of these cells in the lymph node.
💡
Conclusion & Impact:SLE diagnosis should be considered in patients researched for lymphadenopathy etiology.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Lenfadenopati · sistemik lupus eritematozis · başlangıç semptom

Abstract

Lymphadenopathy (LAP) is defined as abnormality in the size and character of lymph node. Lymphadenopathy emerges due to increase of inflammatory cells in lymph node or invasion of these cells in the lymph node. Lymphadenopathy can occur in any age group, in symptomatic or asymptomatic patients, and in a single site or at multiple sites. Causes of generalized lymphadenopathy include infections, autoimmune diseases, malignancies, histiocytoses, storage diseases, benign hyperplasia, and drug reactions. In LAP etiology, collagen tissue diseases hold an important place. The most common autoimmune causes of LAP are rheumatoid arthritis, systemic lupus erythematosus (SLE) and Sjogren syndrome. In this case, we presented a case who was researched for generalized lymphadenopathy and diagnosed with SLE. SLE diagnosis should be considered in patients researched for lymphadenopathy etiology.

Özet

Lenfadenopati (LAP), lenf düğümünün boyut ve karakterindeki anormallik olarak tanımlanır. Lenfadenopatineoplastik veya inflamatuar hücrelerin lenf nodunda çoğalması veya lenf nodunu invazyonu sonucu oluşabilir.Lenfadenopati geniş bir hastalık tablosu sonucunda gelişebilir. Yaygın lenfadenopati sebepleri arasındaenfeksiyonlar, otoimmun hastalıklar, malignensiler, histiyositozlar, depo hastalıkları, hiperplaziler ve ilaçetkileşimleri sayılabilir. Lenfadenopati etyolojisinde kollajen doku hastalıkları önemli yer tutmaktadır. En sıklenfadenopatiye neden olan otoimmun hastalıklar romatoid artrit, sistemik lupus eritematozis (SLE) ve Sjögrensendromudur. Bu olguda yaygın lenfadenopati nedeni ile araştırılan ve SLE tanısı alan bir olguyu sunduk.Lenfadenopati nedeniyle tetkik edilen hastalarda kollajen doku hastalıklarını ve özellikle de SLE'u göz önündebulundurmamız gerektiğini bu yazıda vurgulamak istedik

🔖

Cite This Article

TÜRKBEYLER, İ. H., PEHLİVAN, Y., ÇÖMEZ, G., ZENGİN, O., GÖKTEPE, F., ONAT, A. M. (2011). Diagnosis of Systemic Lupus Erythematosus in a Patient with Generalized Lymphadenopathy: A Case Report. Meandros Medical And Dental Journal, Cilt: 12 Sayı: 2, 45–47. https://ajindex.com/articles/1002727

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Twist CJ, Link MP. Assessment of lymphadenopathy in children. Pediatr Clin NorthAm 2002;49:1009-25
  2. Karnath BM. Approach to the patient with lymphadenopathy. Hosp Physician 2005;41:29-33
  3. Ferrer R. Lymphadenopathy: Differential diagnosis and evaluation.Am Fam Physician 1998;58:1313-20
  4. Rood MJ, ten Cate R, van Suijlekom-Smit LW, et al. Childhood onset systemic lupus erythematosus: clinical presentation and prognosis in 31 patients. Scand J Rheumatol 1999;28:222-8
  5. Brunner HI, Silverman ED, To T, et al. Risk factors for damage in childhood onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002;46:436-4
  6. Hochberg M. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40(9):1725
  7. Benseler S, Silverman ED. Systemic lupus erythematosus. Rheum Dis Clin N Am 2007;33:471- 98
  8. Iqbal S, Sher MR, Good RA, et al.: Diversity in presenting manifestations of systemic lupus erythematosus in children. J Pediatr 1999;135:500-5
  9. Bader-Meunier B, Quartier P, Deschenes G, et al. Childhood-onset systemic lupus erythematosus. Arch Pediatr 2003;10.147-57
  10. Melikoglu MA, Melikoglu M. The clinical importance of lymphadenopathy in systemic lupus erythematosus. Acta Reumatol Port 2008;33(4):402-6
  11. Calgüneri M, Oztürk MA, Ozbalkan Z, Akdogan A, Ureten K, Kiraz S, Ertenli I. Frequency of lymphadenopathy in rheumatoid arthritis and systemic lupus erythematosus. J Int Med Res 2003;31:345-9
  12. Chandrasekaran AN, Rajendran CP, Ramakriahan S, Madhavan R, Parthiban M. Childhood systemic lupus erythematosus in South India. Indian J Pediatr 1994;61:223-9
  13. Cassidy JT, Sullivan DB, Petty RE. Lupus nephritis and encephalopaty. Prognosis in 58 children. Arthritis Rheum 1977;20 (Suppl):351-4 14. Boddaert J, Huiong DLT, Amoura Z, Wechsler B, Goudeau P, Piette J-C. Late onset systemic lupus erythematosus: a personal serie of 47 patients and pooled analysis of 714 cases in the literature. Medicine 2004;83:348-59 15. Biner B, Acunaş B, Karasalihoğlu S, Vatansever U. Systemic lupus erythematosus presenting with generalized lymphadenopathy. Turk J Pediatr 2001;43(1):94-6